Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
Investigation of the genetic background of familial hypercholesterolemia in a Turkish cohort and its clinical implications
Kındış E, Aygün S, Ertürk B, et al.
Journal:
J Clin Lipidol

First published: February 21, 2025 DOI: 10.1016/j.jacl.2025.02.016
View
- Share
Articles
The Year in Cardiovascular Medicine 2024: the top 10 papers in dyslipidaemias
Tokgozoglu L, Orringer C, Catapano AL
Journal:
Eur Heart J

First published: February 19, 2025 DOI: 10.1093/eurheartj/ehaf077
View
- Share
Articles
Long-Term Lipid Lowering With Evolocumab in Older Individuals
Al Said S, O’Donoghue ML, Ran X, et al.
Journal:
J Am Coll Cardiol

First published: February 11, 2025 DOI: 10.1016/j.jacc.2024.11.019
View
- Share
Articles
Integration of Apolipoprotein B into the SCORE2 Framework: Implications for Cardiovascular Risk Prediction
Wong WK, Takeuchi F, Thao LTP, et al.
Journal:
Eur J Prev Cardiol

First published: January 29, 2025 DOI: 10.1093/eurjpc/zwaf039
View
- Share
Articles
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
van Oortmerssen JAE, Mulder JWCM, van der Bijl MF, et al.
Journal:
Curr Atheroscler Rep

First published: January 28, 2025 DOI: 10.1007/s11883-025-01275-1
View
- Share
Articles
SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis
Mazer CD, Moody AR, Teoh H, et al.
Journal:
Circulation

First published: January 28, 2025 DOI: 10.1161/CIRCULATIONAHA.124.072285
View
- Share
Articles
Inflammation in atherosclerosis: a Big Idea that has underperformed so far
Williams KJ
Journal:
Curr Opin Lipidol

First published: January 23, 2025 DOI: 10.1097/MOL.0000000000000973
View
- Share
Articles
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
Elshorbagy A, Vallejo-Vaz AJ, Barkas F, et al.
Journal:
Eur Heart J

First published: January 13, 2025 DOI: 10.1093/eurheartj/ehae791
View
- Share
Articles
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials
Rivera FB, Cha SW, Linnaeus Louisse C, et al.
Journal:
JACC Adv

First published: January 10, 2025 DOI: 10.1016/j.jacadv.2024.101549
View
- Share
Articles
Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials
Tchang BG, Knight MG, Adelborg K, et al.
Journal:
Obesity (Silver Spring)

First published: January 5, 2025 DOI: 10.1002/oby.24202
View
- Share
Articles
Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL
Shishikura D, Kataoka Y, Nicholls SJ, et al.
Journal:
J Clin Lipidol

First published: January 3, 2025 DOI: 10.1016/j.jacl.2024.12.019
View
- Share
Articles
New Approaches to Lipoproteins for the Prevention of Cardiovascular Events
Fujino M, Di Giovanni G, Nicholls SJ
Journal:
J Atheroscler Thromb

First published: December 28, 2024 DOI: 10.5551/jat.RV22031
View
- Share

1 2 3 4 5

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

Investigation of the genetic background of familial hypercholesterolemia in a Turkish cohort and its clinical implications

Kındış E, Aygün S, Ertürk B, et al.

Articles

The Year in Cardiovascular Medicine 2024: the top 10 papers in dyslipidaemias

Tokgozoglu L, Orringer C, Catapano AL

Articles

Long-Term Lipid Lowering With Evolocumab in Older Individuals

Al Said S, O’Donoghue ML, Ran X, et al.

Articles

Integration of Apolipoprotein B into the SCORE2 Framework: Implications for Cardiovascular Risk Prediction

Wong WK, Takeuchi F, Thao LTP, et al.

Articles

Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women

van Oortmerssen JAE, Mulder JWCM, van der Bijl MF, et al.

Articles

SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis

Mazer CD, Moody AR, Teoh H, et al.

Articles

Inflammation in atherosclerosis: a Big Idea that has underperformed so far

Williams KJ

Articles

Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

Elshorbagy A, Vallejo-Vaz AJ, Barkas F, et al.

Articles

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials

Rivera FB, Cha SW, Linnaeus Louisse C, et al.

Articles

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials

Tchang BG, Knight MG, Adelborg K, et al.

Articles

Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL

Shishikura D, Kataoka Y, Nicholls SJ, et al.

Articles

New Approaches to Lipoproteins for the Prevention of Cardiovascular Events

Fujino M, Di Giovanni G, Nicholls SJ

Articles

Investigation of the genetic background of familial hypercholesterolemia in a Turkish cohort and its clinical implications

Kındış E, Aygün S, Ertürk B, et al.

Share

Articles

The Year in Cardiovascular Medicine 2024: the top 10 papers in dyslipidaemias

Tokgozoglu L, Orringer C, Catapano AL

Share

Articles

Long-Term Lipid Lowering With Evolocumab in Older Individuals

Al Said S, O’Donoghue ML, Ran X, et al.

Share

Articles

Integration of Apolipoprotein B into the SCORE2 Framework: Implications for Cardiovascular Risk Prediction

Wong WK, Takeuchi F, Thao LTP, et al.

Share

Articles

Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women

van Oortmerssen JAE, Mulder JWCM, van der Bijl MF, et al.

Share

Articles

SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis

Mazer CD, Moody AR, Teoh H, et al.

Share

Articles

Inflammation in atherosclerosis: a Big Idea that has underperformed so far

Williams KJ

Share

Articles

Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

Elshorbagy A, Vallejo-Vaz AJ, Barkas F, et al.

Share

Articles

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a): A Meta-Analysis and Meta-Regression of Randomized Controlled Trials

Rivera FB, Cha SW, Linnaeus Louisse C, et al.

Share

Articles

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials

Tchang BG, Knight MG, Adelborg K, et al.

Share

Articles

Characterization of lipidic plaque features in association with LDL-C<70 mg/dL and lipoprotein(a) <50 mg/dL

Shishikura D, Kataoka Y, Nicholls SJ, et al.

Share

Articles

New Approaches to Lipoproteins for the Prevention of Cardiovascular Events

Fujino M, Di Giovanni G, Nicholls SJ

Share